Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

In vivo studies with chimeric toxins. Interleukin-2 fusion toxins as immunosuppressive agents.

In vivo studies with chimeric toxins. Interleukin-2 fusion toxins as immunosuppressive agents. Targeted Diagn Ther. 1992; 7:383-93.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.